76,900 Shares in Hemab Therapeutics Holdings, Inc. $COAG Bought by State Street Corp
MarketBeat
State Street Corp bought a new stake in Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 76,900 shares of the company's stock, valued at approximately $2,825,000. State Street
NASDAQ:COAG